Biosyntia raises €11.5 million for biobased biotin
In Denmark, precision fermentation firm Biosyntia has closed an €11.5 million (US$11.6 million) Series B funding round that it will use to launch the world’s first biobased vitamin B7. ECBF lead led the funding, with participation from existing investors Sofinnova Partners and Novo Seeds, the early-stage investment and company creation team of Novo Holdings A/S. […]














